This second volume of the Special Issue on Nidoviruses is a continuation of the first volume published in December 2014. Both issues contain a selection of papers presented in the "XIIIth INTERNATIONAL NIDOVIRUS SYMPOSIUM", held in Salamanca, Spain, on June 1st--6th, 2014. These symposia are held every three years to assemble scientists from around the world who are doing research on *Nidoviruses*. This large order of enveloped, plus strand RNA viruses consists of many genera and species in the *Coronaviridae*, *Arteriviridae*, and *Roniviridae* families, including many important human and veterinary pathogens, as well as several recently discovered insect viruses in the *Mesoniviridae* family. There are now six human coronaviruses (CoVs) that cause diseases, ranging in severity from generally mild respiratory infections due to HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, to highly virulent lower respiratory tract infections caused by SARS-CoV and MERS-CoV. SARS-CoV emerged in 2002--2003 and had a fatality rate of around 10%, but close to 50% in patients over 65 years of age. The recently emerging (summer 2012) MERS-CoV has spread to more than 21 countries, with at least 1030 laboratory-confirmed cases of human infection reported by WHO, including at least 381 deaths (as of February 28th 2015).

CoVs are emerging and re-emerging viruses that can mutate to extend their host range, potentially causing devastating pandemics. Human CoVs apparently were zoonotic viruses that adapted to human-to-human transmission. Surveillance of wild life has shown that SARS-CoV and MERS-CoV were likely derived from bats, being civet cats and camels the most likely intermediate hosts for SARS-CoV and MERS-CoV, respectively, which can spread the virus to humans. To determine additional intermediate hosts is a high priority to prevent the continuing rapid spread of MERS-CoV. The rapid development of novel vaccines and antiviral therapies against CoVs that cause acute respiratory syndromes like SARS and MERS is an important priority for governments and public health agencies worldwide. Similarly, animal CoVs such as a highly virulent porcine epidemic diarrhea virus (PEDV) have reemerged in China in 2010 and soon later (2013) in the United States, affecting 31 states and causing a 10% loss of newborn pigs, now extending to Canada and Mexico. In addition, a previously unknown porcine delta CoV (SDCoV), causing lesions similar to those produced by genetically distinct TGEV and PEDV, was confirmed in China in 2012, and in the States in 2014 affecting 17 states with an average of 7% of the pig population seropositive.

In order to generate a key publication that brings together most of the information discussed during the XIIIth Nidovirus Symposium, we decided to assemble two Special Issues on Nidoviruses, to disseminate among scientists from around the world the updated information on MERS-CoV and other Nidoviruses concerning their molecular biology, virus entrance, pathogenesis, determinants of virulence, mechanisms of transmission and epidemiology, phylogeny, host range, diagnosis, strategies for prevention, and development of vaccines and antiviral therapies. Previous Nidovirus Symposia led to international collaborations that have been very important in expediting research on newly emerging and re-emerging Nidoviruses.

In this second volume, 14 chapters have been included. In these chapters an overview of the state of the art in the Nidovirus field is being offered to the reader. These chapters have been organized in five sections. In the first one, *virus entry and assembly* are addressed in one chapter on the interaction between cell proteins and the coronavirus S protein (C. Schwegmann-Weßels). The second main topic of the special issue addresses *viral gene expression and genome replication*. This theme is covered by four chapters, including a comprehensive review of nidovirus helicases (A. Gorbalenya), new insights into the contribution of paired membrane structures in CoV replication (V. Thiel), the nucleotide composition of the human CoV genome (B. Berkhout), and the proteolytic processing of the porcine respiratory and reproductive syndrome virus (PRRSV) replicase, a member of the *Arteriviridiae* family (Y. Fang). The third topic, *virus-host interaction and pathogenesis*, is covered by reviews on the emergence of Middle East respiratory syndrome CoV (MERS-CoV) (I. Mackay), the functions of CoV nsp1 in the regulation of host and viral gene expression (S. Makino), the evasion of antiviral immune response by PRRSV (F. Wen-Hai), functional analyses of unique proteins encoded by the simian hemorrhagic fever virus (M. Brinton), host cell proteases as determinants of CoV tropism and pathogenesis (J. Millet), and host-PRRSV1 interactions in piglet infection (J.P. Frossard). A fourth subject in the section of *epidemiology, evolution and emerging viruses* has been documented in one chapter on the phylogenetic impact of the re-emergence of outlier strains of Equine Arteritis Virus (F. Steinbach). The last section on *disease control strategies* includes two chapters, one on subunit vaccines against MERS-CoV based on the viral receptor binding domain (D. Lanying), and another one on different forms of the canine coronavirus type I accessory gp3 protein identified in cats (S. Le Poder).

We certainly hope that you will find the content of this Nidoviruses II special issue, and the previous one, informative and scientifically rewarding, and that they will provide you updated information on Nidoviruses.
